ClinicalTrials.Veeva

Menu

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

U

Universitätsmedizin Mannheim

Status

Unknown

Conditions

Granulomatosis With Polyangiitis (Wegener's Disease)
Sarcoidosis
Non-specific Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Pulmonary Healthy Controls
Interstitial Lung Disease

Treatments

Device: body plethysmography
Device: impulse oscillometry
Device: multiple breath washout tests

Study type

Observational

Funder types

Other

Identifiers

NCT02827734
MBW-ILD

Details and patient eligibility

About

Current diagnostic tools used in interstitial lung disease (ILD) do not meet the challenges set by the complex pathophysiology of this heterogenous group. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various ILDs.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • known or suspected interstitial lung disease

Exclusion criteria

  • pregnancy
  • inability to participate

Trial design

50 participants in 2 patient groups

interstitial lung disease
Description:
patients with known or suspected ILD such as idiopathic pulmonary fibrosis, non-specific interstitial pneumonia, sarcoidosis, granulomatosis with polyangiitis
Treatment:
Device: body plethysmography
Device: impulse oscillometry
Device: multiple breath washout tests
pulmonary healthy controls
Description:
patients without known or suspected pulmonary disease
Treatment:
Device: body plethysmography
Device: impulse oscillometry
Device: multiple breath washout tests

Trial contacts and locations

1

Loading...

Central trial contact

Frederik Trinkmann, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems